Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tally Levy

Showing results (41-50 of 70) with videos related to

Pageof 7
Sort By:
Journal of Minimally Invasive Gynecology|December 29, 2020
Anatomic Asymmetry in Sentinel Lymph Node Detection in Endometrial CancerOri Tal, Ehud Grinstein, Elinor Goshen, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 26, 2013
Weekly topotecan for recurrent ovarian, fallopian tube and primary peritoneal carcinoma: tolerability and efficacy study--the Israeli experienceTamar Safra, Tara Berman, Adelya Yachnin, et al.
Acta Oncologica (Stockholm, Sweden)|June 9, 2006
Heavily pretreated ovarian cancer patients treated by single-agent gemcitabine. A retrospective outcome comparison between platinum-sensitive and platinum-resistant patientsTamar Safra, Ilan Ron, Mona Boaz, et al.
Gynecologic Oncology|May 19, 2009
Combined weekly carboplatin and paclitaxel as primary treatment of advanced epithelial ovarian carcinomaTamar Safra, Joseph Menczer, Rinat Molho Bernstein, et al.
Gynecologic Oncology|July 16, 2013
Weekly carboplatin with paclitaxel compared to standard three-weekly treatment in advanced epithelial ovarian carcinoma--a retrospective studyTamar Safra, Sivan Shamai, Julia Greenberg, et al.
Journal of Medical Case Reports|July 29, 2010
Treatment of ovarian cancer ascites by intra-peritoneal injection of diphtheria toxin A chain-H19 vector: a case reportAya Mizrahi, Abraham Czerniak, Patricia Ohana, et al.
Nanoscale|January 7, 2020
An ovarian spheroid based tumor model that represents vascularized tumors and enables the investigation of nanomedicine therapeuticsManu Smriti Singh, Meir Goldsmith, Kavita Thakur, et al.
Surgical Oncology|May 20, 2022
Predicting the rate of adjuvant postoperative chemo/radiation in cervical cancer with tumor size ≥2 cm and <4 cm: An Israeli Gynecologic Oncology Group studyOfer Gemer, Ahmet Namazov, Alon Ben-Arie, et al.
Maturitas|May 24, 2021
The diagnosis of endometrial cancer in women with asymptomatic endometrial polyp does not increase survival rates: an israel gynecologic oncology group studyAhmet Namazov, Limor Helpman, Ram Eitan, et al.
Journal of Translational Medicine|August 7, 2009
Development of targeted therapy for ovarian cancer mediated by a plasmid expressing diphtheria toxin under the control of H19 regulatory sequencesAya Mizrahi, Abraham Czerniak, Tally Levy, et al.
Pageof 7

Showing results (41-50 of 70) with videos related to

Sort By:
Pageof 7
Journal of Minimally Invasive Gynecology|December 29, 2020
Anatomic Asymmetry in Sentinel Lymph Node Detection in Endometrial CancerOri Tal, Ehud Grinstein, Elinor Goshen, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 26, 2013
Weekly topotecan for recurrent ovarian, fallopian tube and primary peritoneal carcinoma: tolerability and efficacy study--the Israeli experienceTamar Safra, Tara Berman, Adelya Yachnin, et al.
Acta Oncologica (Stockholm, Sweden)|June 9, 2006
Heavily pretreated ovarian cancer patients treated by single-agent gemcitabine. A retrospective outcome comparison between platinum-sensitive and platinum-resistant patientsTamar Safra, Ilan Ron, Mona Boaz, et al.
Gynecologic Oncology|May 19, 2009
Combined weekly carboplatin and paclitaxel as primary treatment of advanced epithelial ovarian carcinomaTamar Safra, Joseph Menczer, Rinat Molho Bernstein, et al.
Gynecologic Oncology|July 16, 2013
Weekly carboplatin with paclitaxel compared to standard three-weekly treatment in advanced epithelial ovarian carcinoma--a retrospective studyTamar Safra, Sivan Shamai, Julia Greenberg, et al.
Journal of Medical Case Reports|July 29, 2010
Treatment of ovarian cancer ascites by intra-peritoneal injection of diphtheria toxin A chain-H19 vector: a case reportAya Mizrahi, Abraham Czerniak, Patricia Ohana, et al.
Nanoscale|January 7, 2020
An ovarian spheroid based tumor model that represents vascularized tumors and enables the investigation of nanomedicine therapeuticsManu Smriti Singh, Meir Goldsmith, Kavita Thakur, et al.
Surgical Oncology|May 20, 2022
Predicting the rate of adjuvant postoperative chemo/radiation in cervical cancer with tumor size ≥2 cm and <4 cm: An Israeli Gynecologic Oncology Group studyOfer Gemer, Ahmet Namazov, Alon Ben-Arie, et al.
Maturitas|May 24, 2021
The diagnosis of endometrial cancer in women with asymptomatic endometrial polyp does not increase survival rates: an israel gynecologic oncology group studyAhmet Namazov, Limor Helpman, Ram Eitan, et al.
Journal of Translational Medicine|August 7, 2009
Development of targeted therapy for ovarian cancer mediated by a plasmid expressing diphtheria toxin under the control of H19 regulatory sequencesAya Mizrahi, Abraham Czerniak, Tally Levy, et al.
Pageof 7